Journal of Commercial Biotechnology: January 2012 issue now available

The January 2012 issue of the Journal of Commercial Biotechnology is now available. Contents include Original Articles, From the Boardroom, From the Classroom, Legal and Regulatory Update, and Book Reviews.

Individual papers are available for purchase. Subscription options are posted at , and you may also request that your librarian subscribe at .

Table of Contents


Exciting changes
Yali Friedman


Bacterial proteins: A new class of cancer therapeutics
Ananda Mohan Chakrabarty
Industrial biotechnology – Markets and industry structure
Gunter Festel, Christian Detzel, Ruth Maas
Options to Change Medicare Payment for Outpatient Prescription Drugs and Biotechnology Products
Thomas Barker, Maia Larsson
The Emergence of Bio-Clusters in Egypt and South Africa
Ramazan Uctu, Nirvana Shanalee Pillay
Patent litigation in India and interim injunctions — An evolving jurisprudence
Rajashree Sharma, Dinesh Kumar Sharma

From the Boardroom

Digital health investment opportunities abound, but standouts deliver disruptive change
G. Steven Burrill
Strategies for Collaboration Agreements Focusing on Innovation
Pamela Cox
Biomarketing strategy and tactics 101 PART I of III
Dimitris Dogramatzis

From the Classroom

The University of Colorado Certificate Program in Bioinnovation and Entrepreneurship: An Interdisciplinary, Cross-Campus Model
Madhavan Parthasarathy, David Forlani, Arlen Meyers

Legal and Regulatory Updates

EU Legal & Regulatory Update
Ewan Grist
Post-Grant Review: The Good, the Bad and the Ugly for Biotechnology Companies
Smitha Uthaman, Deborah Lu, Thomas Kowalski

Book Reviews

Book Review: Constructing and Deconstructing Patents by Irah H. Donner
David B. Orange
Book Review: Plunkett’s Biotech & Genetics Industry Almanac 2012
Barry J. Marenberg

For more information, see the Journal of Commercial Biotechnology at

Comments are closed.